Glutathione S-transferase GSTT2 polymorphism and outcome in patients with colorectal cancer

Dianne E. Bamber*, Philip G. Board, Marjorie Coggan, James B. Elder, Mark Deakin, Ramesh Rajagopal, A. Sergei Fawole, Richard C. Strange, Anthony A. Fryer

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)

    Abstract

    We have developed polymerase chain reaction (PCR) based assays to examine 3 polymorphisms in GSTT2 in patients with colorectal cancer. Our results suggest that two of the sites are in linkage disequilibrium with each other and with GSTT1 genotype. Clinical parameters such as Duke's stage, differentiation, tumour location, survival, family history and presence of nodes were also investigated. We identified significant associations between GSTT2 polymorphisms and Dukeís stage. This preliminary data suggests that polymorphism at GSTT2 may be significant in determining outcome in colorectal cancer.

    Original languageEnglish
    Pages (from-to)98-99
    Number of pages2
    JournalChemico-Biological Interactions
    Volume133
    Issue number1-3
    Publication statusPublished - 28 Feb 2001

    Fingerprint

    Dive into the research topics of 'Glutathione S-transferase GSTT2 polymorphism and outcome in patients with colorectal cancer'. Together they form a unique fingerprint.

    Cite this